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Summary
 
The pathogenic role of antineutrophil cytoplasmic autoantibodies (ANCA) remains controver-
sial because of the difficulty in explaining how extracellular ANCA can interact with intracel-
lular primary granule constituents. It has been postulated that cytokine priming of neutrophils
(PMN), as may occur during a prodromal infection, is an important trigger for mobilization of
granules to the cell surface, where they may interact with ANCA. We show by electron mi-
croscopy that apoptosis of unprimed PMN is also associated with the translocation of cytoplas-
mic granules to the cell surface and alignment just beneath an intact cell membrane. Immuno-
fluorescent microscopy and FACS
 
Ò
 
 analysis demonstrate reactivity of ANCA-positive sera and
antimyeloperoxidase antibodies with apoptotic PMN, but not with viable PMN. Moreover,
we show that apoptotic PMN may be divided into two subsets, based on the presence or ab-
sence of granular translocation, and that surface immunogold labeling of myeloperoxidase oc-
curs only in the subset of PMN showing translocation. These results provide a novel mecha-
nism that is independent of priming, by which ANCA may gain access to PMN granule
components during ANCA-associated vasculitis.
 
A
 
ntineutrophil cytoplasmic autoantibodies (ANCA)
 
1
 
 are
associated with systemic vasculitides, especially Wege-
ner’s granulomatosis and microscopic polyarteritis (1–4).
ANCA are also seen with idiopathic crescentic glomerulo-
nephritis without immune deposits (2), and several other
inflammatory or rheumatic diseases (3, 4). These autoAb
are mainly directed against proteins in PMN primary gran-
ules and monocyte lysosomes (5). When detected by indi-
rect immunofluorescence (IF) of ethanol-fixed PMN, there
are two major patterns of ANCA staining—cytoplasmic
(C-ANCA) and perinuclear (P-ANCA) (2). The major
C-ANCA Ag is proteinase 3 (PR3) (6), a 29 kD serine
proteinase. The major P-ANCA Ag is myeloperoxidase
(MPO) (2). Although PR3 and MPO are located in the
primary granules of PMN, ethanol fixation leads to solubi-
lization and nuclear redistribution of MPO, leading to an
artifactual perinuclear staining pattern (2, 7). Other minor
ANCA Ag have been described, leading to both C- and
P-ANCA patterns, but these account for 
 
,
 
5% of positive
ANCA (5).
The pathogenic role of ANCA remains controversial, in
part because it is difficult to explain how extracellular ANCA
interact with intracellular primary granule components. Al-
 
1
 
Abbreviations used in this paper:
 
 ANCA, antineutrophil cytoplasmic au-
toantibodies; C-ANCA, ANCA with cytoplasmic staining pattern on in-
direct immunofluorescence; CHX, cycloheximide; EM, electron micros-
copy; GBM, glomerular basement membrane; IF, immunofluorescence;
MPO, myeloperoxidase; P-ANCA, ANCA with perinuclear staining pat-
tern on indirect immunofluorescence; PI, propidium iodide; PR3, pro-
teinase 3.
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though several models have been put forth (8–10), most
authors invoke some “priming” event by which the PMN
is preactivated (11), whereby primary granules translocate
to the cell surface without releasing their contents. Priming
may occur in vivo during a prodromal infection or other
inflammatory process (12), and can be induced in vitro by
various cytokines (e.g., TNF-
 
a
 
), LPS, or chemotactic fac-
tors (10, 11, 13). ANCA can activate primed PMN in vitro,
leading to degranulation and release of reactive oxygen spe-
cies (10, 13, 14).
We present data supporting an alternative model in
which PMN priming need not be invoked. PMN are
short-lived cells, having a circulatory half-life of several
days. Death occurs by apoptosis (15), an energy-requiring
process that leads to cellular “suicide” (16). We show that
PMN apoptosis is associated with translocation of cytoplas-
mic granules to the cell surface, thereby leading to in-
creased reactivity with anti-MPO Ab and ANCA sera. Our
results suggest a novel mechanism that is independent of
priming, by which ANCA may interact with PMN granule
components during ANCA-associated vasculitis.
 
Materials and Methods
 
Materials.
 
Ficoll-Hypaque (Lymphocyte Separation Medium)
was obtained from Organon Technika (Durham, NC), bisbenza-
mide (Hoechst dye or H-33342) from Molecular Probes, Inc.
(Eugene, OR), dextran from Pharmacia AB (Uppsala, Sweden),
polyclonal rabbit anti–human MPO Ab from Calbiochem-Nova-
biochem Corp. (La Jolla, CA), FITC-conjugated goat anti–rabbit
IgG from Cappel Laboratories (Durham, NC); FITC-conjugated
goat anti–human IgG (Fc-specific) from Incstar Co. (Stillwater,
MN); gold-conjugated (10 nm) goat anti–rabbit IgG from Ted
Pella, Inc. (Redding, CA); and RPMI 1640 medium and penicillin-
streptomycin solution from GIBCO BRL (Gaithersburg, MD).
All other materials, including BSA, propidium iodide (PI), cyclo-
heximide (CHX), and Dulbecco’s PBS with calcium and magne-
sium chloride (PBS
 
1
 
), were obtained from Sigma Chemical Co.
(St. Louis, MO).
 
Patients.
 
ANCA sera (
 
n
 
 
 
5
 
 10) and sera from patients with
anti–glomerular basement membrane (anti-GBM) disease (
 
n
 
 
 
5
 
 2)
were a gift from Dr. John Niles (Massachusetts General Hospital,
Boston, MA). ANCA staining patterns were determined by indi-
rect IF on ethanol-fixed normal human PMN (17). As confirmed
by ELISA (18), the antigenic specificity of all P-ANCA sera (
 
n
 
 
 
5
 
5) was MPO, and that of all C-ANCA sera (
 
n
 
 
 
5
 
 5) was PR3.
P-ANCA sera showed no cross-reactivity for PR3, and C-ANCA
sera showed no cross-reactivity for MPO. All ANCA sera were of
high titer (
 
.
 
100 U of activity; 17). For anti-GBM sera, autoreac-
tivity for the noncollagenous domain of type IV collagen (Good-
pasture epitope) was confirmed by Western blotting, with no
cross-reactivity for ANCA Ag. Normal sera (
 
n
 
 
 
5
 
 12) were ob-
tained from healthy volunteers. All sera were heat-inactivated for
1 h at 56
 
8
 
C before use.
 
Isolation and Culture of PMN.
 
PMN were isolated from hep-
arinized venous blood from healthy volunteers by standard tech-
niques of Ficoll-Hypaque density gradient centrifugation and dex-
tran sedimentation (19). PMN were suspended in culture
medium (RPMI 1640 with 10% heat-inactivated human serum
and 1% penicillin–streptomycin solution).
Resultant suspensions contained 
 
>
 
95% PMN, as assessed by
cytospin and Wright-Giemsa staining. Viability was 
 
>
 
99%, as as-
sessed by trypan blue exclusion. Importantly, other investigators
have shown that this technique yields PMN with a quiescent
phenotype under basal conditions by multiple criteria: (
 
a
 
) low
levels of heterotypic adhesion (20); (
 
b
 
) no superoxide anion gen-
eration (21); (
 
c
 
) no generation of 5-lipoxygenase–derived eico-
sanoids (22); and (
 
d
 
) L-selectin expression with relatively low lev-
els of CD11b/CD18 (data not shown). Upon receptor-triggered
stimulation, PMN upregulate CD11b/CD18, shed L-selectin, show
increased adhesiveness for endothelial cells, and generate reactive
oxygen species and 5-lipoxygenase products (19–22).
 
Induction of Apoptosis.
 
Freshly isolated PMN were cultured at
1–2 
 
3
 
 10
 
6
 
 cells/ml and were incubated for 18 h at 37
 
8
 
C in a hu-
midified atmosphere containing 5% CO
 
2
 
. PMN were incubated
under identical conditions with CHX (10 
 
m
 
g/ml) to induce in-
creased apoptosis (23).
 
IF Staining with Human Sera.
 
After induction of apoptosis,
PMN were cooled to 4
 
8
 
C, washed in PBS
 
1
 
, and suspended in
staining medium (RPMI 1640, 1% BSA, 25 mM Tris, pH 8.3).
PMN were then treated with serum at a constant ratio of 50 
 
m
 
l
serum per 1–2 
 
3
 
 10
 
6
 
 cells for 60 min. Bound Ab was detected
with FITC-conjugated goat anti–human IgG at a 1:20 dilution in
staining medium. All incubations were performed at 4
 
8
 
C to pre-
vent capping and shedding of bound Ab. PMN were then treated
Figure 1. ANCA bind to the surface of unprimed apoptotic PMN.
Unprimed apoptotic PMN were treated with polyclonal anti-MPO Ab,
normal serum, anti-GBM serum, and high titer C- and P-ANCA sera.
Cells were photographed under epifluorescence microscopy for Hoechst,
PI, and FITC. All cells excluded PI and so had intact cell membranes.
Apoptotic PMN with nuclear condensation comprised two distinct sub-
populations with bright or faint Hoechst staining. Surface FITC staining
of apoptotic PMN by ANCA sera and anti-MPO Ab occurred more
commonly in apoptotic PMN with fainter Hoechst staining. 
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with Hoechst dye for 10 min at 37
 
8
 
C and placed on ice. Hoechst
dye, a cell-permeant supravital DNA stain, identified the con-
densed chromatin characteristic of apoptotic cells (24). PI was
added immediately before IF microscopy or FACS
 
Ò
 
 analysis
(Becton Dickinson & Co., Mountain View, CA). Permeant cells,
identified by uptake of PI, were excluded from IF and FACS
 
Ò
 
studies.
Viable PMN were defined as PI negative with faint nuclear
Hoechst staining. Apoptotic PMN were defined as PI negative
with bright nuclear Hoechst staining. By these criteria, when
PMN were incubated without CHX, 28.0 
 
6
 
 9.0% were viable
and 54.7 
 
6
 
 11.4% were apoptotic. When PMN were incubated
with CHX, 17.5 
 
6
 
 8.3% were viable and 54.7 
 
6
 
 11.7% were apop-
totic.  The remaining PMN in each case were PI positive and
therefore excluded. The vast majority of excluded cells were
smaller than viable PMN and likely represented apoptotic PMN
that had progressed to postapoptosis (or secondary necrosis). Ne-
crotic cells, identified by increased cell size and PI uptake, regu-
larly comprised 
 
,
 
1% of the final cell population.
 
IF Staining with Polyclonal Anti-MPO Ab.
 
PMN suspensions
were treated with polyclonal rabbit anti-human MPO Ab at a 1:50
or 1:100 dilution (2 
 
m
 
l per 1-2 
 
3
 
 10
 
6
 
 cells) in staining medium.
Bound Ab was detected with FITC-conjugated goat anti–rabbit
IgG at a 1:64 dilution. In all other aspects, the protocols for stain-
ing PMN with anti-MPO Ab or human sera were identical.
 
IF Microscopy and FACS
 
Ò
 
 Analysis.
 
Cells were photographed
under epifluorescence microscopy for visualizing Hoechst, PI,
and FITC staining in the same cells. FACS
 
Ò
 
 analysis was per-
formed on an Epics ESP Flow Cytometer (Coulter Electronics,
Hialeah, FL) with an UV-enhanced argon laser. Hoechst fluores-
cence was performed by excitation with 
 
,
 
5 mW of UV laser
light (351–364 nm multiline). PI and FITC fluorescence were
performed with 15 mW of 488 nm blue laser light. A gated am-
plifier option allowed spatial beam separation leading to minimal
spectral overlap among Hoechst, PI, and FITC fluorescence. De-
tection of Hoechst, PI, and FITC fluorescence was achieved us-
ing 405-, 525-, and 575-nm bandpass optical filters, respectively.
Data were analyzed by Epic Elite software (Coulter Electronics).
 
FACS
 
Ò
 
 Sorting of PMN.
 
PMN were stained with polyclonal
anti-MPO Ab as described above. Populations of PMN within
specific clusters (high FITC vs. low FITC staining) were sorted at
a flow rate of 800–1,000 cells/s.
 
Assessment of PMN Morphology by Electron Microscopy.
 
Sorted PMN
were centrifuged at 500 
 
g
 
 for 15 min, fixed with 2.5% glutaralde-
hyde in PBS for 1 h at 4
 
8
 
C, and washed three times in Sabatini’s
solution (PBS with 6.8% sucrose). Samples were postfixed with
1% osmium tetroxide (1 h), washed three times in Sabatini’s solu-
tion, passed through a graded series of alcohols (30, 50, 70, 90,
and 100% for 15 min each), and treated with propylene oxide (15
min), a 1:1 Epon-propylene oxide mix (1 h), and three changes
Figure 2. Anti-MPO Ab stains a subpopula-
tion of unprimed apoptotic PMN. Freshly iso-
lated PMN were treated with anti-MPO Ab
(a), P-ANCA serum (b), or C-ANCA serum (c),
and were analyzed by FACSÒ for Hoechst and
FITC staining. Also, PMN were cultured over-
night to induce apoptosis, treated with anti-
MPO Ab, and were analyzed by FACSÒ for
Hoechst and FITC staining (d and e). PI-posi-
tive cells were excluded from analysis (region
defined in 2 d). A minority of PI-positive cells
were necrotic (,1% of total PMN), based on
increased cell size. The majority had decreased
cell size, and were felt to represent postapop-
totic cells that had lost membrane integrity.
These apoptotic cells were excluded, since loss
of membrane integrity might permit binding of
ANCA to cytoplasmic primary granules. The
remaining cells, including viable and apoptotic
PMN, were examined for nuclear staining by
Hoechst dye and surface FITC staining by anti-
MPO Ab or human sera. 
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in pure Epon (3 h, 3 h, and overnight). Polymerization occurred
overnight at 64
 
8
 
C. Ultrathin sections (
 
z
 
50 nm) were cut with
MT2 Sorvall ultramicrotome, stained with lead citrate and uranyl
citrate, and examined by transmission electron microscopy (EM)
(100CX; JEOL U.S.A. Inc., Peabody, MA) at 60 kV using a 20-
 
m
 
m
objective aperture.
 
Preembedding Immunogold Staining of PMN for EM.
 
PMN were
washed in PBS and resuspended in PBS with 1% egg albumin.
After a 10-min incubation on ice, PMN were centrifuged at 500 
 
g
 
for 15 min and resuspended in PBS with 0.5% egg albumin.
Polyclonal rabbit anti–human MPO Ab was added at 1:50 dilu-
tion, and PMN were incubated on ice for 30 min. After three
washes in PBS, PMN were treated with gold-conjugated goat
anti–rabbit IgG at a 1:10 dilution for 30 min on ice. After three
washes in PBS, PMN were centrifuged at 500 
 
g
 
 for 15 min and
fixed by slowly adding 1.25% glutaraldehyde in 0.1 M cacodylate
buffer without disturbing the pellet. Processing for transmission
EM was performed as indicated above for sorted PMN.
 
Statistics.
 
Individual sera were tested at least twice on separate
days with consistent results. Data are presented as the mean 
 
6
 
 SD
of the two experiments. Statistical significance was determined by
a two-tailed Student’s 
 
t
 
 test.
 
Results
 
ANCA Bind to the Surface of Unprimed Apoptotic PMN.
 
Initial IF studies used high titer sera for P-ANCA and
C-ANCA. To ensure that PMN isolation did not induce
priming or activation, we incubated freshly isolated PMN
with both ANCA sera. No surface staining of PMN was
observed (not shown). Additional evidence confirming that
isolation and culture of PMN did not induce priming or
activation is given below.
To assess potential translocation of primary granule con-
stituents to the cell surface during apoptosis, we incubated
ANCA sera with PMN that had been cultured overnight
to induce apoptosis. Both P-ANCA and C-ANCA sera
bound specifically to the surface of apoptotic PMN, as
shown by a correlation between surface FITC staining and
the presence of condensed chromatin in PI-negative PMN
(Fig. 1). Apoptotic PMN treated with anti-MPO Ab gave a
similar staining pattern. In contrast, minimal staining oc-
curred for apoptotic PMN that were incubated with nor-
mal or anti-GBM sera.
Figure 3. ANCA sera stain a subpopulation of
unprimed apoptotic PMN. Apoptotic PMN were
treated with anti-MPO Ab, normal serum, anti-
GBM serum, and C-ANCA and P-ANCA sera.
PMN, selected as described in the legend of Fig. 2,
were examined for Hoechst and surface FITC
staining. Left-hand panels depict scatter plots of
Hoechst vs. PI staining. Middle panels are gated to
include only PI-negative cells, and depict scatter
plots of Hoechst vs. FITC staining. Shaded histo-
grams in the right-hand panels are derived from the
scatter plots and depict relative cell number as a
function of log FITC fluorescence. Unshaded his-
tograms represent control data from healthy volun-
teers. 
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Surface Staining with ANCA Sera Is Restricted to a Subpopu-
lation of Apoptotic PMN.
 
Three-color FACS
 
Ò
 
 analysis con-
firmed and extended these observations. Freshly isolated
PMN treated with anti-MPO Ab yielded a single population
with low Hoechst and low FITC staining (Fig. 2 
 
a
 
). Incu-
bation with normal serum (not shown) or P-ANCA (Fig. 2 
 
b
 
)
and C-ANCA (Fig. 2 
 
c
 
) sera also yielded a single popula-
tion with low Hoechst and low FITC staining. In contrast,
PMN that had been cultured overnight to induce apoptosis
and treated with anti-MPO Ab comprised three distinct
populations (Fig. 2 d): (a) a low Hoechst and low FITC
population, likely representing viable PMN, based on simi-
lar staining to freshly isolated PMN; (b) a bright Hoechst
and low FITC population corresponding to apoptotic PMN
in Fig. 1 that were not recognized by anti-MPO Ab; and
(c) a bright Hoechst and high FITC population represent-
ing apoptotic PMN that apparently express MPO on their
cell surface. Three similar populations were observed when
apoptotic PMN were treated with P-ANCA and C-ANCA
sera, anti-GBM serum, or normal serum (Fig. 3).
These observations were confirmed using pooled data
from P-ANCA (n 5 5) or C-ANCA (n 5 5) sera. Data
were analyzed in two ways. First, we compared the mean
channel FITC fluorescence for each of the three PMN
populations (Fig. 4). The mean channel fluorescence for
P-ANCA and C-ANCA sera did not differ from that for
normal sera (n 5 12) among the viable or low FITC apoptotic
populations. In contrast, among high-FITC apoptotic PMN,
the mean channel fluorescences for P-ANCA and C-ANCA
sera were z43 (P ,0.002) and 23 (P ,0.05) that for nor-
mal sera. Identical results were obtained when apoptosis
was induced with (Fig. 4 a) or without (Fig. 4 b) CHX.
Second, we determined the percentage of total PMN
that showed surface FITC staining above a threshold level
of fluorescence, defined by the horizontal bars in Fig. 3.
For PMN cultured without CHX, the percentage of posi-
tive cells was 2.7 6 0.8% for normal sera, 16.6 6 14.5% for
C-ANCA sera (P ,0.1), and 24.6 6 9.3% for P-ANCA
sera (P ,0.01) (Fig. 5). For PMN cultured with CHX, the
percentage was 4.4 6 1.9% for normal sera, 22.9 6 14.7% for
C-ANCA sera (P ,0.05), and 36.9 6 12.0% for P-ANCA
sera (P ,0.005) (Fig. 5).
Several points merit emphasis. First, surface FITC stain-
ing of viable PMN did not differ between ANCA-positive
and ANCA-negative sera. Combined with the data shown
in Fig. 2, these results imply that neither isolation nor cul-
ture of PMN induced priming. Thus, recognition of apop-
totic PMN by ANCA sera may be specific to the apoptotic
process. Second, surface staining by ANCA sera is seen
Figure 4. ANCA sera stain a subpopulation of unprimed apoptotic
PMN. PMN apoptosis was induced by overnight culture with (a) or
without (b) CHX. Scatter plots were gated into the same three subpopu-
lations shown in Fig. 3. Mean channel FITC fluorescence for each sub-
population was compared among normal sera (n 5 12), C-ANCA sera
(n 5 5), and P-ANCA sera (n 5 5). PMN were selected as described in
the legend of Fig. 2.
Figure 5. Surface staining of unprimed apoptotic PMN correlates with
the presence of ANCA. PMN apoptosis was induced as described in the
legend of Fig. 4. Positively staining PMN were defined as cells whose
log-FITC fluorescence was greater than a threshold equal to the mean
channel fluorescence with normal human sera for the high-FITC apop-
totic population plus five standard deviations (see Fig. 4). Horizontal bars
in the right-hand panels of Fig. 3 indicate the regions of positive log
FITC fluorescence. PMN staining was compared among normal sera (n 5
12), C-ANCA sera (n 5 5), and P-ANCA sera (n 5 5). PMN were se-
lected as described in the legend of Fig. 2.2236 ANCA Autoantibodies Recognize Unprimed Apoptotic Neutrophils
only in a subpopulation of apoptotic PMN. In fact, recog-
nition of apoptotic PMN by ANCA sera seems to be an
“all-or-nothing” phenomenon. Apoptotic PMN not rec-
ognized by ANCA displayed low FITC staining compara-
ble to that of viable PMN. Thus, recognition of apoptotic
PMN by ANCA sera appears to define a specific stage or
morphologic feature of apoptosis, and only within this spe-
cific subpopulation of PMN does binding by ANCA sera
differ from that by ANCA-negative sera. Finally, the exist-
ence of the same three populations using normal and anti-
GBM sera suggests that the subpopulation of apoptotic
PMN recognized by ANCA sera may be characterized by
additional surface changes besides expression of MPO or
PR3. Such changes may include decreased surface charge,
decreased lectin binding sites, membrane reorganization,
and/or altered surface ultrastructure (15, 25, 26).
Primary Granules Translocate to the PMN Cell Surface Dur-
ing Apoptosis. To determine directly whether surface stain-
Figure 6. Cytoplasmic gran-
ules translocate to the cell surface
during apoptosis. PMN, cultured
overnight with CHX, were
stained with anti-MPO Ab and
sorted into two populations by
FITC staining. (A) Low FITC
staining. Shown are a viable (up-
per) and an apoptotic PMN
(lower). The viable PMN has a
multisegmented nucleus (N),
many granules throughout the
cytoplasm, and an irregular cell
outline with membrane ruffling.
The apoptotic PMN shows coa-
lescence of the nuclear lobes,
preservation of cytoplasmic gran-
ules, and a smooth rounded cell
outline. (B) High-FITC staining.
Shown is an apoptotic PMN
sharing many features of apopto-
sis as within the low-FITC pop-
ulation, except for fewer cyto-
plasmic granules, many aligned
just beneath an intact cell mem-
brane (arrow heads). (C) High
FITC staining. Shown are two
apoptotic PMN, with nuclear
disintegration (*) and decreased
numbers of cytoplasmic granules,
many again aligned beneath an
intact cell membrane. (D) High-
FITC staining. Shown is an apop-
totic PMN with nuclear disinte-
gration  and loss of cell membrane
integrity (arrow heads). This PMN
is postapoptotic. Original magni-
fications: (A) 38,700; (B and C)
310,800; (D) 315,000.2237 Gilligan et al.
ing by ANCA sera reflected primary granule translocation,
we sorted PMN into two populations by the level of FITC
staining and assessed their morphology by EM.
The low FITC population contained two phenotypes.
Viable PMN had typical morphologic features of mature
PMN, including intact cell and nuclear membranes, multi-
segmented nuclei, granular appearance of the nuclear chro-
matin, large numbers of cytoplasmic granules, and an irregular
cell outline characterized by membrane ruffling. Apoptotic
PMN within the low FITC population showed classic fea-
tures of apoptosis (15, 25, 27), including coalescence of the
nuclear lobes into a single body, condensed chromatin,
preservation of cytoplasmic granules, maintenance of cell
membrane integrity, and a smooth rounded cell outline.
Representative examples of a viable and FITC-negative
apoptotic PMN are shown in Fig. 6 a.
The high FITC population also contained two pheno-
types, both apoptotic. The first resembled apoptotic PMN
found in the low FITC population, except for fewer cyto-
plasmic granules, many being aligned just beneath an intact
cell membrane (Fig. 6 b). The second represented a later
phase of apoptosis, characterized by nuclear disintegration,
maintenance of cell membrane integrity, and diminished
numbers of cytoplasmic granules, many again aligned just
beneath the cell membrane (Fig. 6 c). Recent data suggest
that disintegration of nuclear material may comprise a later
step in PMN apoptosis before loss of membrane integrity
(27). Loss of nuclear structure offers an explanation for the
observation noted above, that surface FITC staining of
apoptotic PMN correlates with less bright Hoechst stain-
ing. The high-FITC population also contained PMN with
nuclear disintegration in association with loss of cell mem-
brane integrity. Shedding of primary granules from these
cells can be seen in areas of membrane integrity loss (Fig. 6 d).
PMN Apoptosis Is Associated with Diminished Cellular 
Content of ANCA Ag
Given these morphologic features, we hypothesized that
translocated primary granules may be shed from the cell
surface in the form of membrane-enclosed apoptotic bod-
ies. Thus, when apoptosis has progressed to the stage of nu-
clear disintegration and loss of membrane integrity, there
should be diminished numbers of primary granules within
the cytoplasm. To test this, we regated selected FACSÒ
analyses to include all apoptotic PMN, irrespective of PI
entry, and assessed FITC staining in relation to PI staining
(Fig. 7 a and b). Three distinct populations were observed:
(a) a PI-negative and low FITC population comprised of
viable PMN and apoptotic PMN whose primary granules
have not yet undergone translocation; (b) a PI-negative and
high FITC population comprised of apoptotic PMN with
granular translocation; and (c) a PI-positive and intermedi-
ate FITC population (consistent with loss of primary gran-
ules) containing apoptotic PMN that have progressed to
postapoptosis (see Fig. 9). This result is noteworthy in that
FITC staining within the PI-positive population reflects
the full complement of primary granules, both surface and
cytoplasmic, whereas FITC staining within the PI-negative
population represents only those granules that have under-
gone translocation.
Immunogold Labeling Localizes MPO on the Surface of Apop-
totic PMN. To confirm ANCA binding to the apoptotic
PMN surface and determine the ultrastructural site of bind-
ing, we used gold-conjugated anti–rabbit IgG to detect
bound rabbit anti-MPO Ab. We restricted labeling to the
cell surface by fixing PMN only after treatment with both
Ab. Surface labeling was seen for the same two phenotypes
of apoptotic PMN identified by high FITC sorting. These
included early apoptotic PMN whose primary granules had
translocated to the cell surface (Fig. 8 B) and late apoptotic
PMN that had undergone nuclear disintegration (Fig. 8 A).
Gold particles were localized over primary granules, as well
as within “puffs” extending from the cell surface. The ab-
sence of gold particles within the cytoplasm attests to the
preservation of membrane integrity during processing. Cy-
toplasmic staining may be seen in an apoptotic cell with
Figure 7. PMN apoptosis leads to decreased cellular content of ANCA
Ag. PMN were cultured overnight, treated with P-ANCA (a) or C-ANCA
(b) sera, and then analyzed by FACSÒ for PI and FITC staining. All PMN
were included.2238 ANCA Autoantibodies Recognize Unprimed Apoptotic Neutrophils
nuclear disintegration that has lost membrane integrity (Fig.
8 A, left). Labeling was specific for translocation of primary
granules, as shown by the virtual absence of labeling for vi-
able PMN (Fig. 8 C) or apoptotic PMN that had not un-
dergone primary granule translocation (Fig. 8 D).
Discussion
Although ANCA are a highly sensitive and specific
marker for Wegener’s granulomatosis and microscopic poly-
arteritis, (1–4), their pathogenic role remains uncertain.
The most difficult problem has been to explain how extra-
cellular ANCA interact with intracellular primary granule
components. For this reason, most models invoke a “prim-
ing” event in which cytoplasmic primary granules translo-
cate to the PMN cell surface (8–10, 13, 14, 28). We show
that ANCA Ag are expressed on the surface of apoptotic
PMN. Translocation of primary granules occurs as a natural
consequence of apoptosis, without priming. Moreover, we
show that, once expressed on the surface of apoptotic
PMN, primary granule components may interact with cir-
culating ANCA.
Figure 8. Immunogold label-
ing localizes MPO on the surface
of apoptotic PMN. PMN were
cultured overnight with CHX
and treated with anti-MPO Ab,
followed by gold-conjugated
anti–rabbit IgG. To restrict la-
beling to the PMN surface, fixa-
tion occurred after treatment
with both Ab. (A and B) Two
apoptotic PMN with surface
gold labeling. Both show de-
creased numbers of cytoplasmic
granules, many aligned beneath
an intact cell membrane (arrow
heads). The PMN in B has a coa-
lesced nucleus (N), whereas that
in A has undergone nuclear dis-
integration (*). Boxed areas,
showing areas of surface gold la-
beling, are enlarged within in-
sets. These PMN are representa-
tive of the same two phenotypes
sorted into the high FITC popu-
lation for Fig. 6. (C) No surface
gold labeling occurs on viable
PMN. (D) No surface gold la-
beling occurs on apoptotic PMN
without primary granule translo-
cation. Original magnifications:
(A and B) 335,000; (insets A
and B) 354,000; (C) 312,300;
(D) 314,800.2239 Gilligan et al.
Surface expression of ANCA Ag seems most prominent
during the later phases of apoptosis. PMN undergoing apop-
tosis seem to progress through several discrete phases (Fig. 9).
Early apoptotic PMN show most of the classic morpho-
logic features of apoptosis (27). Cells exclude PI and stain
brightly with Hoechst dye. PMN moving to a later phase
of apoptosis undergo several changes that correlate with
surface ANCA recognition. Late apoptotic PMN still ex-
clude PI but show decreased Hoechst staining. EM shows
nuclear disintegration and decreased numbers of cytoplas-
mic granules, many aligned just beneath an intact cell
membrane. Although translocation of primary granules is
more easily appreciated during later phases of apoptosis, it
may also be seen in early apoptotic PMN before nuclear
disintegration.
We speculate that, once translocated to the cell surface,
cytoplasmic granules are shed in the form of membrane-
enclosed apoptotic bodies. This would explain both the de-
creased number of granules seen by EM in late apoptotic
PMN and the marked decrease in total cellular content of
ANCA Ag seen by FACSÒ analysis of postapoptotic PMN.
Phagocytic clearance of apoptotic bodies protects tissues
from an otherwise harmful exposure to cytoplasmic granu-
lar contents (25). Although we cannot exclude the possibil-
ity that apoptotic PMN release the contents of their cyto-
plasmic granules directly into the extracellular space by
degranulation, this seems very unlikely. Given the short
circulatory half-life of PMN and the large number of PMN
released daily by the bone marrow, release of even a frac-
tion of PMN granular contents without phagocytic clear-
ance would produce overwhelming inflammatory injury.
Immunogold labeling confirmed the surface expression
of ANCA Ag by apoptotic PMN, but did not identify the
structural basis for this expression. Surface labeling was fre-
quently associated with “puffs” extending outward from
the cell membrane. Such “puffs” may represent a residual
after shedding of granules as apoptotic bodies or even after
degranulation. Alternatively, surface expression of ANCA
Ag may represent a normal event that is for some reason
augmented during apoptosis. Surface expression of lactofer-
rin (29, 30) and PR3 (30) on normal nonapoptotic PMN
has been previously described by immunogold labeling and
FACSÒ analysis.
A major consideration was the potential inadvertent prim-
ing of PMN during isolation or overnight culture. However,
the data argue sharply against priming as an explanation for
our findings. First, isolation of PMN by Ficoll-Hypaque
density gradient centrifugation and dextran sedimentation
has been shown to yield PMN with a quiescent phenotype
(see Materials and Methods) (19–22). Second, freshly iso-
lated PMN incubated with anti-MPO Ab or ANCA sera
comprised a single population with low Hoechst and low
FITC staining. Third, in PMN cultured to induce apopto-
sis, surface staining by ANCA sera or anti-MPO Ab was
limited to apoptotic PMN. In contrast, surface staining of
viable PMN was no different for ANCA-positive vs. ANCA-
negative sera. Finally, translocation of cytoplasmic granules
was restricted to apoptotic PMN by EM. Viable PMN, dis-
playing morphologic features of mature PMN, showed no
translocation. Together, these data indicate that transloca-
tion of cytoplasmic granules is specific to the apoptotic pro-
cess, and not an artifact of PMN isolation and culture.
Our data may have relevance to the pathogenesis of
ANCA-related disorders. In most models (8–10, 13, 14),
apoptosis could substitute for PMN priming, with ANCA
binding to the surface of apoptotic and primed PMN.
Recent studies have indicated the importance of the Fc re-
gion of ANCA in PMN activation. After binding of ANCA
to the cell surface, full activation of PMN seems to depend
on binding of ANCA to a second or the same PMN
through interaction of ANCA Fc regions with FcgRIIa
(CD32) (9, 28, 31, 32). Engagement of b2 integrins may
also be a requirement for ANCA-induced activation (28).
While it is unclear from these studies whether one or both
of the bridged PMN is activated, previous work has shown
that engagement of FcgRIIa can mediate PMN activation
Figure 9. PMN undergoing apoptosis progress through discrete phases.
During early apoptosis, nuclear chromatin condenses and nuclear lobes
coalesce into a single body. Nucleus disintegration occurs with movement
into late apoptosis. Translocation and loss of cytoplasmic primary granules
is more distinct during late-phase apoptosis, but also occurs in early apop-
totic PMN before nuclear disintegration. ANCA binding correlates with
cytoplasmic granular translocation. PMN eventually move into a postapo-
ptotic phase, during which there is loss of cell membrane integrity.2240 ANCA Autoantibodies Recognize Unprimed Apoptotic Neutrophils
(33, 34). In binding of ANCA to the surface of an apop-
totic PMN, Fc-dependent bridging could occur via Fcg-
RIIa on a nonapoptotic PMN as in current models (9, 28,
31, 32) or, alternatively, via FcgRIIa on a second or the
same apoptotic PMN, since apoptotic PMN have been
shown to express normal levels of FcgRIIa (35). We are
currently investigating whether apoptotic PMN can be ac-
tivated by ANCA, either through Ag recognition or Fcg-
RIIa engagement.
Finally, our results may have implications for the initia-
tion of autoimmunity in ANCA-associated disorders. Our
data are consistent with growing evidence that apoptotic
Ag are the natural targets for many autoAb (24, 36–39). For
example, many anti-DNA autoAb seem to be directed
against nucleosomal DNA–histone complexes, produced as
a result of internucleosomal cleavage during apoptosis. Nu-
cleosomes are a powerful immunogen for autoreactive T cell
clones derived from mice with SLE (37). Furthermore, sev-
eral prominent nuclear and cytoplasmic autoAg targeted in
SLE can be found on the surface of apoptotic keratinocytes
in the form of either apoptotic bodies or smaller so-called
apoptotic blebs (36). These autoAg included nucleosomal
DNA, small nuclear ribonucleoproteins, and cytoplasmic
RNP (SS-A/Ro, and SS-B/La).
We have recently shown that antiphospholipid Ab from
patients with primary antiphospholipid syndrome or SLE
recognize the plasma protein b2-glycoprotein I complexed
to the surface of apoptotic thymocytes (24). These data and
our current demonstration that ANCA Ag can be found on
the surface of apoptotic PMN suggest that apoptotic cells
may comprise a major source of immunogen in ANCA-
associated disorders and autoimmune diseases such as SLE.
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